Human β2-adrenergic receptor polymorphisms: No association with essential hypertension in black or white Americans

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 6, 2000, Pages 670-675

  Xie, Hong Guang ^a,b   Stein, C Michael ^a,b   Kim, Richard B ^a,b   Gainer, James V ^a,b   Sofowora, Gbenga ^a,b   Dishy, Victor ^a,b   Brown, Nancy J ^a,b   Goree, Robert E ^a,b   Haines, Jonathan L ^a,b   Wood, Alastair J J ^a,b  

^a Division of Clinical Pharmacology   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; FEMALE; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NEGRO; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; ALLELE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ETHNOLOGY; GENE SEQUENCE; GENETIC POLYMORPHISM; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0033623880     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.106293     Document Type: Article

References (38)

1. 1. Stein CM, Nelson R, He HB, Wood M, Wood AJJ. Norepinephrine release in the human forearm: effects of epinephrine. Hypertension 1997;30:1078-84.
2. 2. Feldman RD. β-Adrenergic receptor alterations in hypertension: physiological and molecular correlations. Can J Physiol Pharmacol 1987;65:1666-72.
3. 3. Michel MC, Brodde OE, Insel PA. Peripheral adrenergic receptors in hypertension. Hypertension 1990;16:107-20.
4. 4. Mendlowitz M. Vascular reactivity in systemic arterial hypertension. Am Heart J 1973;85:252-9.
5. 5. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJJ. Low sodium intake corrects abnormality in β-receptor-mediated arterial vasodilation in patients with hypertension: correction with β-receptor function in vitro. Clin Pharmacol Ther 1990;48:87-95.
6. 6. Feldman RD. Defective venous beta-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest 1990;85:647-52.
7. 7. Stein CM, Nelson R, Deegan R, He HB, Wood M, Wood AJJ. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 1995;96:579-85.
8. 8. The HDFP Cooperative Group. Race, education and prevalence of hypertension. Am J Epidemiol 1977;106: 351-61.
9. 9. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-13.
10. 10. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
11. 11. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, et al. Attenuation of isoproterenol-mediated vasodilation in blacks. N Engl J Med 1995;333:155-60.
12. 2C10-adrenergic receptor genotype. Hypertension 1996;27:1210-5.
13. 2-adrenergic receptor locus. Hypertension 1997;29:918-22.
14. 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987;84:46-50.
15. 2-adrenergic receptor and their putative promoter regions. J Biol Chem 1987;262:7321-7.
16. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9414-9.
17. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am J Respir Cell Mol Biol 1995;13:25-33.
18. 2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitization in moderately severe stable asthmatics. Lancet 1997;350:995-9.
19. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 1997;100:3184-8.
20. 2-adrenoceptor polymorphism with vascular reactivity in humans [abstract]. Br J Clin Pharmacol 1998;45:510P.
21. 2-adrenoceptor. Hypertension 1997;30:773-6.
22. 2-Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen Blood Pressure Study. Kidney Int 1998; 53:1455-60.
23. 2-adrenoceptor polymorphism and essential hypertension in a black African population [abstract]. Am J Hypertens 1998;11:6A.
24. 24. Senior PA, Bhopal R. Ethnicity as a variable in epidemiological research. Br Med J 1994;309:327-30.
25. 25. Sheps SG. Overview of JNC VI: new directions in the management of hypertension and cardiovascular risk. Am J Hypertens 1999;12:65S-72S.
26. 26. Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH, et al. Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals. Pharmacogenetics 1999;9:511-6.
27. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 1995;345:1213-4.
28. 2-adrenergic receptor polymorphisms. News Physiol Sci 1995;10: 265-73.
29. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-9.
30. 2-adrenergic receptor and asthma. Am J Respir Crit Care Med 1997;151: S156-62.
31. 2-adrenergic receptor among Turks. Br J Clin Pharmacol 1999;48:761-4.
32. 32. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associated with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997;100:3005-13.
33. 2-adrenergic receptor in nocturnal and nonnocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995; 95:1635-41.
34. 2-Adrenoceptor polymorphisms: are they clinically important? Thorax 1996;51:351-3.
35. 2-Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 1999;33: 1425-30.
36. 2-receptor polymorphism influences agonist-stimulated peripheral blood flow in normal individuals [abstract]. Circulation 1998;98:I393.
37. 2-adrenoceptor genotype Arginine 16Arginine + Glutamate27Glutamate, which confers complete resistance to downregulation in vitro, does not occur in essential hypertension. J Hum Hypertens 1998;12:788-9.
38. 2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 1998;102:1534-9.